Genetic diagnostics firm Singlera nets $152.6m in Series B round

Genetic diagnostics firm Singlera nets $152.6m in Series B round

Microcentrifuge tubes in a rack. Source: National Cancer Institute/Unsplash

15 December, 2020

CICC Capital DT Capital Partners Fu Rong Investment Singlera Genomics.

Printed by Unregistered user on Sat, 12 Jul 2025 11:29:32 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

Chinese VCs Green Pine, Lilly Asia back Singlera's $60m Series A

Chinese genome sequencing specialist MGI grabs $1b in Series B round led by IDG, CPE

Read more from Greater China

Policy & Regulations

Shanghai to consider policy responses to stablecoins, cryptocurrencies

Policy & Regulations

China’s Chery, BYD may have to repay subsidies after audit finds improper claims